Search
for
Sort by
Research 61–90 of 1000+
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Alopecia areata: current concepts
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Under Development JAK Inhibitors for Dermatologic Diseases
- Jak inhibitors in the treatment of alopecia areata - a literature review
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Baricitinib for the Treatment of Alopecia Areata
- Diagnostic Challenges and Treatment Strategies in Neutrophilic Cicatricial Alopecias: A Narrative Review from Conventional Therapies to New Therapeutic Targets
- Inibidores das Janus Associated Kinases na Terapêutica Farmacológica
- Platycladus orientalis Leaf Extract Promotes Hair Growth via Non-Receptor Tyrosine Kinase ACK1 Activation
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes
- Cytokine-targeted treatment in alopecia areata - new possibilities?
- Emerging treatments in alopecia
- Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib
- Treating Alopecia Areata: Current Practices Versus New Directions
- Mechanisms of autophagy and their implications in dermatological disorders
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Reversing Gray Hair: Inspiring the Development of New Therapies Through Research on Hair Pigmentation and Repigmentation Progress
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- Costunolide—A Bioactive Sesquiterpene Lactone with Diverse Therapeutic Potential
- Janus Kinase inhibitors in dermatology: a review
- At the crossroads of 2 alopecias: Androgenetic alopecia pattern of hair regrowth in patients with alopecia areata treated with oral Janus kinase inhibitors
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
- Efficacy of Janus kinase inhibitors in adult patients with alopecia areata
- Androgenetic alopecia: combing the hair follicle signaling pathways for new therapeutic targets and more effective treatment options